Journals / Anatomy / 2015 / Cilt: 9 - Sayı: 3

Histomorphological studies of the liver of Plasmodium-infected albino mice after administration of aqueous leaf extract of Mangifera indica (Linn.)

Journal
Anatomy
Pages
168–176
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significantdecrease (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives:This study was carried out to assess the histomorphological findings of the liver of Plasmodium-infected albinomice following administration of aqueous leaf extract of Mangifera indica.
📊
Key Findings & Data:Methods: Forty-two male albino mice, weighing 20-25 g, were used for this research.
💡
Conclusion & Impact:There was a significantdecrease (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives:This study was carried out to assess the histomorphological findings of the liver of Plasmodium-infected albinomice following administration of aqueous leaf extract of Mangifera indica. Methods: Forty-two male albino mice, weighing 20-25 g, were used for this research. The mice were randomly assignedinto six groups A, B, C, D, E and F (n=7, each). Groups B, C, D, E and F were infected with P. berghei, while group A wasadministered equivalent volume of normal saline. Mice in groups C, D and E were orally administered Mangifera indicaextract (50 mg/kg, 100 mg/kg and 150 mg/kg body weight, respectively) dissolved in 0.2 ml of distilled water for 5 days,and those in group F were orally administered with artesunate for 5 days (3 mg/kg and 1.5 mg/kg body weight on the firstday and on subsequent 4 days, respectively) while groups A and B were administered equivalent volume of distilled water,all administrations starting 72 hours post-infection. The animals were left for another 14 days after treatment. Results: The result showed that the extract treated groups presented dose dependent ameliorative changes in the organization of histoarchitecture such as reduction of collagen fibers, reticular fibers and hemozoins. There was a significantdecrease (p

🔖

Cite This Article

SAKA, O. S., OLAYODE, A. A., OFUSORİ, D. A., OGUNNİYİ, T. A. B. (2022). Histomorphological studies of the liver of Plasmodium-infected albino mice after administration of aqueous leaf extract of Mangifera indica (Linn.). Anatomy, Cilt: 9 - Sayı: 3, 168–176. https://ajindex.com/articles/439556

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Nicholas JW, Breman JG. Malaria and babeiosis; diseases caused by red blood cell parasites. In: Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS, editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw Hill; 2005. p. 1218. World Health Organization. Malaria chemotherapy. WHO tech- nical report series. Geneva: WHO; 1998. 1998. Palmer J. WHO gives indoor use of DDT a clean bill of health for controlling malaria. Indian J Med Sci 2006;60:439-41.
  2. Hall N, Karras M, Raine JD, Carlton JM, Kooij TW, Berriman M, Florens L, Janssen CS, Pain A, Christophides GK, James K, Rutherford K, Harris B, Harris D, Churcher C, Quail MA, Ormond D, Doggett J, Trueman HE, Mendoza J, Bidwell SL, Rajandream MA, Carucci DJ, Yates JR 3rd, KafatosFC, Janse CJ, Barrell B, Turner CM, Waters AP, Sinden RE. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 2005;307:82-6.
  3. Kooij TW, Janse CJ, Waters AP. Plasmodium post-genomics: bet- ter the bug you know? Nat Rev Microbiol 2006;4:344-57. Good MF. The hope but challenge for developing a vaccine that might control malaria. Eur J Immunol 2009;39:939-43. World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: WHO; 1998. 316 p. Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP. Estimation of the total par- asite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005;2:e204. Bartoloni A, Zammarchi L. Clinical aspects of uncomplicated and severe malaria. Mediterr J Hematol Infect Dis 2012;4:e2012026.
  4. Nadjm B, Behrens RH. Malaria: an update for physicians. Infect Dis Clin North Am 2012;26:243-59. World Health Organization. Malaria chemoprophylaxis: problems associated with the chemoprophylaxis of travellers to endemic areas. Wkly Epidemiol Rec 1986;61:109-16. Cook GC. Plasmodium falciparum infection: problems in prophy- laxis and treatment in 1986. Q J Med 1986;61:1091-115. Pillay VV. Modern medical toxicology. 4th ed. New Delhi: Jaypee Publishers; 2013. 460 p. Rouveix B, Bernard J, Michon C. Mefloquine and anacute brain syndrome. Ann Intern Med 1989;110:577-8.
  5. Rupani AB, Amarapurkar AD. Hepatic changes in fatal malaria: an emergingproblem. Ann Trop Med Parasitol 2009;103:119-27.
  6. Whitten R, Milner DA Jr, Yeh MM, Kamiza S, Molyneux ME, Taylor TE. Liver pathology in Malawian children with fatal encephalopathy. Hum Path